BGPT: Paper Review: RAGE as a Receptor of HMGB1 (Amphoterin): Roles in Health and Disease

Explore by Goal

Quick Explanation Copied

Core idea

The review argues that extracellular HMGB1 (amphoterin) engages RAGE (via an HMGB1 C-terminal region) to trigger cytoskeletal remodeling, integrin activation, and pro-inflammatory gene programs (NF-κB, SP1, CREB), contributing to diseases such as inflammation/sepsis, neuroinjury/stroke, autoimmunity, cancer progression, and atherosclerosis—while emphasizing receptor redundancy (RAGE is not the only HMGB1 receptor).

Long Explanation

Visual + skeptical paper review: “RAGE as a Receptor of HMGB1 (Amphoterin): Roles in Health and Disease”

Publication timing in manuscript: received Aug 14 2007; accepted Oct 16 2007 (narrative review).

HMGB1 → RAGE signaling: what the review claims

The review’s mechanistic through-line is: extracellular HMGB1 binds the ectodomain of RAGE (reported Kd ~5–10 nM), then RAGE cytosolic signaling drives MAPK/NF-κB/Sp1/CREB programs, cytoskeletal remodeling (Cdc42/Rac), and rapid integrin activation (Rap1-dependent), with NF-κB–mediated upregulation of RAGE forming a positive feedback loop.

Receptor redundancy: RAGE is central, but not unique

The review explicitly notes that HMGB1 knockout mice have severe early postnatal phenotypes and metabolic/glucose/organ failure issues, whereas RAGE knockout mice appear comparatively healthy—arguing that HMGB1 has additional receptors besides RAGE and that a straightforward one-to-one HMGB1→RAGE mapping is biologically incomplete.

HMGB1 interaction class	Receptor / binding partner	Role described in the review	Evidence granularity (review level)
Primary axis	RAGE	Ectodomain binding; cytosolic tail signaling → MAPKs/NF-κB/Sp1/CREB; motility (Cdc42/Rac) and integrins (Rap1). Includes NF-κB–driven positive feedback upregulating RAGE and adhesion gene programs.	Mechanistic pathway compilation (in vitro + in vivo cited)
Co-receptor / alternative	TLR2 / TLR4	Suggested HMGB1 receptors; proposed cooperation with RAGE for inflammatory responses; differences in activity depending on HMGB1 molecular complexes (e.g., DNA-HMGB1 activates via TLR9 and RAGE).	Review-level integration; structural binding-site details described as incomplete
Candidate coreceptors	Syndecans	HMGB1 reported to bind syndecan-1; syndecans can act as signaling receptors or integrin/growth-factor coreceptors; functional evidence for inflammatory HMGB1 signaling described as scarce.	Binding evidence + limited functional confirmation in inflammation context
Candidate receptor	RPTP / phosphacan	Ectodomain phosphacan binds HMGB1 with reported Kd ~0.3–0.8 nM; functional studies “essentially still lacking” in the review.	High-affinity binding reported; functional pathway evidence missing
Carbohydrate binding components	Sulfoglucuronyl carbohydrates (HNK-1)	HMGB1 binding to SGCs regulates neurite outgrowth and neuronal migration; RAGE carbohydrate region also implicated as affecting HMGB1 binding and neurite outgrowth.	Developmental/neuronal function emphasized

Disease “hotspots” emphasized by the review

This is a textual emphasis map (not a quantitative meta-analysis). It counts which disease topics appear across the review sections: neuronal plasticity/disorders, inflammation (sepsis/RA), tumour spread, and vascular disease (atherosclerosis), plus regulation by nervous system.

Reality check with external mechanistic studies (examples)

The review is 2007 and is narrative; later papers can either reinforce or challenge specific mechanistic claims. Below are concrete examples (from the dataset you provided) that directly target HMGB1→RAGE causality in specific contexts.

Cited study	System / design	Mechanistic claim tested	How it relates to the 2007 review
“RAGE is the Major Receptor for the Proinflammatory Activity of HMGB1 in Rodent Macrophages”	Bone marrow macrophages; genetic knockout mice (RAGE-/-, IL-1RI-/- , TLR2-/-); ELISA & Western blot	Whether HMGB1’s proinflammatory effects require RAGE	Supports the review’s central HMGB1→RAGE pro-inflammatory axis (in a defined immune cell context).
“The redox-sensitive protein HMGB1: intracellular and extracellular roles”	Narrative review with structural modeling described in dataset	How redox state modulates extracellular receptor signaling	Adds a major missing dimension for interpreting 2007 claims: “HMGB1” is not one signal—isoforms/forms differ.
“Activation of toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development”	Human surgical/autopsy tissue; RT-qPCR; immunocytochemistry; IL-1β-treated human astrocyte cultures	Whether HMGB1–TLR/RAGE signaling is activated in epileptogenic lesions	Consistent with the review’s neuroinflammation/plasticity frame, but also shows that HMGB1 mRNA may not always differ while localization does.

Binding affinity claim: HMGB1–RAGE

The review reports HMGB1 binding to RAGE ectodomain with Kd ~5–10 nM.

Skeptical critique: where the review is strong vs uncertain

Strengths (mechanistic coherence):

The review compiles a multi-layer causal-looking pathway: binding → cytosolic signaling → MAPKs/NF-κB/TF output → migration/integrin adhesion → feedback via NF-κB upregulating RAGE.

Major uncertainties / blind spots:

The review treats “HMGB1” largely as a single entity, but HMGB1 is redox- and form-dependent; isoforms can alter extracellular receptor usage and pro-inflammatory vs pro-resolving outcomes.
HMGB1 actions are likely context-dependent (cell type, receptor co-expression, and molecular complex formation). The review itself notes incomplete structural understanding for competitive ligand binding among RAGE ligands and suggests receptor redundancy (TLRs, syndecans, phosphacan, carbohydrate ligands).
As a narrative review, it is susceptible to selection/citation biases and to interpreting heterogeneous experimental models as if they converge on a single dominant mechanism. This is an inherent limitation of literature synthesis rather than a single experimental flaw.

What would most likely disprove or sharply revise the review’s dominant framing?

In well-controlled, receptor-specific experiments, HMGB1-induced migration/integrin activation/cytokine programs would need to persist despite RAGE absence or RAGE-binding disruption—particularly across multiple isoforms/states of HMGB1 (redox forms). The 2026 redox framing makes this falsification strategy more stringent than in 2007.

Mechanistic bottom line (with confidence)

The review’s most defensible core claim is the plausibility of an HMGB1→RAGE signaling axis that can drive migration/adhesion and pro-inflammatory signaling programs, supported by mechanistic pathway descriptions and by later context-specific experimental evidence that RAGE can be a major receptor for HMGB1 inflammatory activity in macrophages.

Confidence level: moderate for “RAGE contributes substantially,” but limited for “RAGE is the dominant universal receptor” because the review itself and later redox-focused framing emphasize complexity (multiple receptors, isoforms, and molecular complex formation).

Go deeper: author-targeted reviews

Feedback:

Updated: April 03, 2026